Dow Jones

39 065,26

-1,53%

DAX

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Bavarian Nordic AS (PK) (BVNRY)
Bavarian Nordic AS (PK) (BVNRY) Actualités

BVNRY

Bavarian Nordic AS (PK) (BVNRY)

Bavarian Nordic AS (PK)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:BVNRY

Date	Heure	Source	Titre	Symbole	Société
22/07/2022	14h10	Benzinga	Benzinga Before The Bell: Snap's Dismal Earnings, Amazon's Healthcare Foray, Robinhood Moves 41B Dogecoin Into Single Wallet And Other Top Financial Stories Friday, July 22	USOTC:BVNRY	Bavarian Nordic AS (PK)
24/05/2022	14h22	TipRanks	Monkeypox Outbreak is Pushing Up Smallpox Vaccine Makers’ Stocks	USOTC:BVNRY	Bavarian Nordic AS (PK)
13/04/2016	17h55	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	USOTC:BVNRY	Bavarian Nordic AS (PK)
12/01/2016	12h02	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-1/a)	USOTC:BVNRY	Bavarian Nordic AS (PK)
05/01/2016	17h52	Edgar (US Regulatory)	Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)	USOTC:BVNRY	Bavarian Nordic AS (PK)
17/04/2015	16h19	InvestorsHub NewsWire	EDISON EQUITY RESEARCH - BAVARIAN NORDIC	USOTC:BVNRY	Bavarian Nordic AS (PK)
24/07/2014	07h56	GlobeNewswire Inc.	Bavarian Nordic Announces First Patient Treated in a Phase 1 Study of MVA-BN(r) Brachyury in Advanced Cancer	USOTC:BVNRY	Bavarian Nordic AS (PK)
28/05/2014	17h12	GlobeNewswire Inc.	Bavarian Nordic Announces Appointment of Paul Chaplin, Ph.D. as President & CEO	USOTC:BVNRY	Bavarian Nordic AS (PK)
15/05/2014	08h06	GlobeNewswire Inc.	Bavarian Nordic to Present Data Combining Its Cancer Immunotherapies With Immune Checkpoint Inhibitors at the 2014 ASCO Annua...	USOTC:BVNRY	Bavarian Nordic AS (PK)
14/05/2014	09h19	GlobeNewswire Inc.	Bavarian Nordic Announces First Quarter 2014 Results	USOTC:BVNRY	Bavarian Nordic AS (PK)
28/04/2014	08h54	GlobeNewswire Inc.	Bavarian Nordic Announces First Patient Treated in a Phase 2 Study Evaluating Its Immunotherapy Candidate CV-301 in Bladder C...	USOTC:BVNRY	Bavarian Nordic AS (PK)
19/03/2014	08h43	GlobeNewswire Inc.	Bavarian Nordic Announces 2013 Full Year Results	USOTC:BVNRY	Bavarian Nordic AS (PK)
21/10/2013	06h00	OTC Markets	Company Name Change	USOTC:BVNRY	Bavarian Nordic AS (PK)
13/07/2013	06h00	OTC Markets	Piggyback Qualified	USOTC:BVNRY	Bavarian Nordic AS (PK)
13/06/2013	14h37	OTC Markets	Venue Change	USOTC:BVNRY	Bavarian Nordic AS (PK)
30/05/2013	12h00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:BVNRY	Bavarian Nordic AS (PK)